These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19261682)

  • 1. Hecate-CGbeta conjugate and gonadotropin suppression shows two distinct mechanisms of action in the treatment of adrenocortical tumors in transgenic mice expressing Simian Virus 40 T antigen under inhibin-alpha promoter.
    Vuorenoja S; Mohanty BP; Arola J; Huhtaniemi I; Toppari J; Rahman NA
    Endocr Relat Cancer; 2009 Jun; 16(2):549-64. PubMed ID: 19261682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted therapy for adrenocortical tumors in transgenic mice through their LH receptor by Hecate-human chorionic gonadotropin beta conjugate.
    Vuorenoja S; Rivero-Müller A; Ziecik AJ; Huhtaniemi I; Toppari J; Rahman NA
    Endocr Relat Cancer; 2008 Jun; 15(2):635-48. PubMed ID: 18509010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of luteinizing hormone analog stimulate gonadal and adrenal tumorigenesis in mice transgenic for the mouse inhibin-alpha-subunit promoter/Simian virus 40 T-antigen fusion gene.
    Mikola M; Kero J; Nilson JH; Keri RA; Poutanen M; Huhtaniemi I
    Oncogene; 2003 May; 22(21):3269-78. PubMed ID: 12761497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel targeted therapy of Leydig and granulosa cell tumors through the luteinizing hormone receptor using a hecate-chorionic gonadotropin beta conjugate in transgenic mice.
    Bodek G; Vierre S; Rivero-Müller A; Huhtaniemi I; Ziecik AJ; Rahman NA
    Neoplasia; 2005 May; 7(5):497-508. PubMed ID: 15967102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenocortical tumorigenesis in transgenic mice: the role of luteinizing hormone receptor and transcription factors GATA-4 and GATA-61.
    Rahman NA; Kiiveri S; Siltanen S; Levallet J; Kero J; Lensu T; Wilson DB; Heikinheimo MT; Huhtaniemi IT
    Reprod Biol; 2001 Jul; 1(1):5-9. PubMed ID: 14666170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct luteinizing hormone action triggers adrenocortical tumorigenesis in castrated mice transgenic for the murine inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene.
    Rilianawati ; Paukku T; Kero J; Zhang FP; Rahman N; Kananen K; Huhtaniemi I
    Mol Endocrinol; 1998 Jun; 12(6):801-9. PubMed ID: 9626655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic mice expressing inhibin α-subunit promoter (inhα)/Simian Virus 40 T-antigen (Tag) transgene as a model for the therapy of granulosa cell-derived ovarian cancer.
    Chrusciel M; Doroszko M; Stelmaszewska J; Li X; Ziecik AJ; Coelingh-Bennink HJ; Huhtaniemi I; Rahman NA
    Reprod Biol; 2014 Mar; 14(1):25-31. PubMed ID: 24607252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of hecate-chorionic gonadotropin beta conjugate in therapy of lutenizing hormone receptor expressing gonadal somatic cell tumors.
    Rivero-Müller A; Vuorenoja S; Tuominen M; Wacławik A; Brokken LJ; Ziecik AJ; Huhtaniemi I; Rahman NA
    Mol Cell Endocrinol; 2007 Apr; 269(1-2):17-25. PubMed ID: 17363137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenocortical tumorigenesis in transgenic mice expressing the inhibin alpha-subunit promoter/simian virus 40 T-antigen transgene: relationship between ectopic expression of luteinizing hormone receptor and transcription factor GATA-4.
    Rahman NA; Kiiveri S; Rivero-Müller A; Levallet J; Vierre S; Kero J; Wilson DB; Heikinheimo M; Huhtaniemi I
    Mol Endocrinol; 2004 Oct; 18(10):2553-69. PubMed ID: 15256532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of gonadotropins inhibits gonadal tumorigenesis in mice transgenic for the mouse inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene.
    Kananen K; Rilianawati ; Paukku T; Markkula M; Rainio EM; Huhtaniemi I
    Endocrinology; 1997 Aug; 138(8):3521-31. PubMed ID: 9231807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadectomy permits adrenocortical tumorigenesis in mice transgenic for the mouse inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene: evidence for negative autoregulation of the inhibin alpha-subunit gene.
    Kananen K; Markkula M; Mikola M; Rainio EM; McNeilly A; Huhtaniemi I
    Mol Endocrinol; 1996 Dec; 10(12):1667-77. PubMed ID: 8961275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenocortical tumorigenesis, luteinizing hormone receptor and transcription factors GATA-4 and GATA-6.
    Vuorenoja S; Rivero-Muller A; Kiiveri S; Bielinska M; Heikinheimo M; Wilson DB; Huhtaniemi IT; Rahman NA
    Mol Cell Endocrinol; 2007 Apr; 269(1-2):38-45. PubMed ID: 17337116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth repression in diethylstilbestrol/dimethylbenz[a]anthracene-induced rat mammary gland tumor using Hecate-CGbeta conjugate.
    Zaleska M; Waclawik A; Bodek G; Zezula-Szpyra A; Li X; Janowski T; Hansel WH; Rahman NA; Ziecik AJ
    Exp Biol Med (Maywood); 2004 Apr; 229(4):335-44. PubMed ID: 15044717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadal tumorigenesis in transgenic mice bearing the mouse inhibin alpha-subunit promoter/simian virus T-antigen fusion gene: characterization of ovarian tumors and establishment of gonadotropin-responsive granulosa cell lines.
    Kananen K; Markkula M; Rainio E; Su JG; Hsueh AJ; Huhtaniemi IT
    Mol Endocrinol; 1995 May; 9(5):616-27. PubMed ID: 7565808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate, adrenocortical, and brown adipose tumors in fetal globin/T antigen transgenic mice.
    Perez-Stable C; Altman NH; Brown J; Harbison M; Cray C; Roos BA
    Lab Invest; 1996 Feb; 74(2):363-73. PubMed ID: 8780156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GnRH antagonist treatment of malignant adrenocortical tumors.
    Doroszko M; Chrusciel M; Stelmaszewska J; Slezak T; Anisimowicz S; Plöckinger U; Quinkler M; Bonomi M; Wolczynski S; Huhtaniemi I; Toppari J; Rahman NA
    Endocr Relat Cancer; 2019 Jan; 26(1):103-117. PubMed ID: 30400009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a lytic peptide conjugated to beta HCG on ovarian cancer: studies in vitro and in vivo.
    Gawronska B; Leuschner C; Enright FM; Hansel W
    Gynecol Oncol; 2002 Apr; 85(1):45-52. PubMed ID: 11925119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel approach of targeted ablation of mammary carcinoma cells through luteinizing hormone receptors using Hecate-CGbeta conjugate.
    Bodek G; Rahman NA; Zaleska M; Soliymani R; Lankinen H; Hansel W; Huhtaniemi I; Ziecik AJ
    Breast Cancer Res Treat; 2003 May; 79(1):1-10. PubMed ID: 12779076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted destruction of normal and cancer cells through lutropin/choriogonadotropin receptors using Hecate-betaCG conjugate.
    Zaleska M; Bodek G; Jana B; Hansel W; Ziecik AJ
    Exp Clin Endocrinol Diabetes; 2003 May; 111(3):146-53. PubMed ID: 12784188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human prostate cancer cells and xenografts are targeted and destroyed through luteinizing hormone releasing hormone receptors.
    Leuschner C; Enright FM; Gawronska-Kozak B; Hansel W
    Prostate; 2003 Sep; 56(4):239-49. PubMed ID: 12858351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.